Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, B-Cell × Interviews as Topic × 30 days × Clear all

Sponsor

Conditions

Hematopoietic and Lymphatic System Neoplasm 4 Malignant Solid Neoplasm 3 Lung Neoplasms 3 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Multiple Myeloma 2 Hematologic Neoplasms 2 Breast Neoplasms 2 Thyroid Cancer, Papillary 1 Testicular Neoplasms 1 Sarcoma 1 Rectal Neoplasms 1 Pyloric Stenosis, Hypertrophic 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms, Second Primary 1 Mouth Neoplasms 1 Mental Disorders 1 Melanoma 1 Inflammatory Breast Neoplasms 1 Hematopoietic and Lymphoid System Neoplasm 1 Depressive Disorder 1 Depression 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Medullary 1 Cancer Patients 1 Breast Carcinoma In Situ 1 Advanced Malignant Solid Neoplasm 1 Adenocarcinoma, Follicular 1

Interventions

Cyclophosphamide 8 Rituximab 7 Specimen Handling 5 obinutuzumab 4 fludarabine 4 Magnetic Resonance Spectroscopy 4 tazemetostat 3 polatuzumab vedotin 3 pirtobrutinib 3 Vincristine 3 Prednisone 3 Nivolumab 3 Doxorubicin 3 zanubrutinib 2 ibrutinib 2 glofitamab 2 acalabrutinib 2 Biopsy 2 venetoclax 1 tafasitamab 1 sodium-iodide symporter 1 ruxolitinib 1 pomalidomide 1 pembrolizumab 1 palbociclib 1 iberdomide 1 etoposide phosphate 1 decitabine and cedazuridine drug combination 1 cemiplimab 1 brexucabtagene autoleucel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡